| 1 |
LU2314628996 |
JPMorgan Funds - Thematics - Genetic Therapies I (acc) - EUR |
+34,45 % |
+20,27 % |
1,56 |
| 2 |
LU1991432631 |
UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse (SEK) P-acc, SEK |
+36,56 % |
+23,41 % |
1,44 |
| 3 |
LU2053354044 |
JPMorgan Funds - Thematics - Genetic Therapies C2 (acc) - GBP (hedged) |
+32,43 % |
+20,91 % |
1,42 |
| 4 |
LU1120766032 |
Candriam Equities L Biotechnology, I - Capitalisation |
+34,03 % |
+22,36 % |
1,40 |
| 5 |
LU2053353822 |
JPMorgan Funds - Thematics - Genetic Therapies A (acc) - GBP (hedged) |
+31,68 % |
+20,91 % |
1,38 |
|
|
| 52 |
LU1269736911 |
Candriam Equities L Biotechnology, R - Capitalisation |
+26,79 % |
+22,80 % |
1,05 |
|
|
| 116 |
CH0113817123 |
Bellevue Biotech DT CHF |
+15,56 % |
+20,51 % |
0,63 |
| 117 |
LU1176840327 |
Protea Fund - Sectoral Biotech Opportunities Fund PF USD |
+16,14 % |
+22,02 % |
0,61 |
| 118 |
LU3110815787 |
CPR Invest - Biodiversity - IF1 EURH1 - Acc |
+8,97 % |
+11,69 % |
0,53 |
| 119 |
LU3110815944 |
CPR Invest - Biodiversity - IF2 EURH1 - Acc |
+8,75 % |
+11,69 % |
0,52 |
| 120 |
LU1711916616 |
Protea Fund - Sectoral Biotech Opportunities Fund IF H CHF |
+11,52 % |
+21,92 % |
0,40 |